Research
Recent Publications
A Receptor Story: Insulin Resistance Pathophysiology and Physiologic Insulin Resensitization’s Role as a Treatment Modality
Reversal of Diabetic Retinopathy in two Patients Following the use of Physiologic Insulin Resensitization
Physiologic Insulin Resensitization as a Treatment Modality for Insulin Resistance Pathophysiology
Dynamic Diabetes Solutions: Physiologic Insulin Resensitization
Improved Kidney Function Following Physiologic Insulin Resensitization Treatment Modality
Case Series: Reversal of Diabetic Neuropathy Utilizing Physiologic Insulin Resensitization
A Receptor Story: Insulin Resistance Pathophysiology and Physiologic Insulin Resensitization’s Role as a Treatment Modality
Reversal of Diabetic Retinopathy in two Patients Following the use of Physiologic Insulin Resensitization
Physiologic Insulin Resensitization as a Treatment Modality for Insulin Resistance Pathophysiology
Dynamic Diabetes Solutions: Physiologic Insulin Resensitization
Improved Kidney Function Following Physiologic Insulin Resensitization Treatment Modality
Case Series: Reversal of Diabetic Neuropathy Utilizing Physiologic Insulin Resensitization
Other Publications
“Economic Costs of Diabetes in the U.S. 2017” (Published online in Diabetes Care Mar, 2018)
Per Brian Loveridge, MD; “Diabetes represents the most expensive medical condition in America. The prevalence continues to rise, with one out of two adults having either diabetes or pre-diabetes. Greater focus and attention is needed to address the complications of this epidemic that plagues both the U.S., and the world at large. We want to be a part of the solution with our physiologic insulin treatments.”
“ACP Recommends Less Intensive Glycemic Control Targets for Type 2 Diabetes” (Ann Internal Medicine, Mar 2018)
Per Brian Loveridge, MD; “Detailed scientific exploration of how impaired insulin production leads to a breakdown in carbohydrate metabolism. In pre-diabetes, the body tries to overcome progressive insulin resistance by producing higher levels of insulin. Unfortunately, this creates a “toxic” environment for these receptors. With increasing insulin “resistance,” a patient goes from impaired glucose metabolism to type 2 diabetes. We aim to restore the natural physiology toward improved glycemic control.”